NCT04429815View on ClinicalTrials.gov

Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19

CompletedOBSERVATIONAL
Enrollment

195

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Smoking Behaviors
Interventions
DIAGNOSTIC_TEST

Serological test for COVID-19.

Serological test for COVID-19 performed as part of standard of care.

Trial Locations (1)

Unknown

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04429815 - Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19 | Biotech Hunter | Biotech Hunter